Pifithrin-α, p-nitro, cyclic
- CAS No.
- 60477-38-5
- Chemical Name:
- Pifithrin-α, p-nitro, cyclic
- Synonyms
- PFN-α;p-Nitro-CyclicPifithrin-α;p-Nitro-Cyclic Pifithrin-a;Cyclic pifithrin-α-p-nitro;p-nitro-Cyclic Pifithrin-α;Pifithrin-α, p-nitro, cyclic;Pifithrin-alpha, p-Nitro, Cyclic;p-nitro Cyclic Pifithrin-.alpha.;Pifithrin-α, p-Nitro, Cyclic;Pifithrin-α, p-Nitro, Cyclic, 10 mM in DMSO
- CBNumber:
- CB43136760
- Molecular Formula:
- C15H13N3O2S
- Molecular Weight:
- 299.35
- MDL Number:
- MOL File:
- 60477-38-5.mol
Melting point | 233-234 °C(Solv: N,N-dimethylformamide (68-12-2); water (7732-18-5)) |
---|---|
Density | 1.53±0.1 g/cm3(Predicted) |
storage temp. | -20C |
solubility | ≤1mg/ml in dimethyl formamide |
form | Yellow solid |
pka | 6.14±0.20(Predicted) |
color | Light yellow to yellow |
UNSPSC Code | 12352200 |
NACRES | NA.77 |
Pifithrin-α, p-nitro, cyclic price More Price(9)
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
Sigma-Aldrich | 506154 | Pifithrin-α, p-Nitro, Cyclic - CAS 60477-38-5 - Calbiochem A cell-permeable p53 inhibitor that exhibits 10-fold higher potency and 50% longer half-life than Pifithrin-α. |
60477-38-5 | 5mg | $172 | 2024-03-01 | Buy |
Cayman Chemical | 17848 | p-nitro-Cyclic Pifithrin-α ≥95% | 60477-38-5 | 1mg | $37 | 2024-03-01 | Buy |
Cayman Chemical | 17848 | p-nitro-Cyclic Pifithrin-α ≥95% | 60477-38-5 | 5mg | $108 | 2024-03-01 | Buy |
Cayman Chemical | 17848 | p-nitro-Cyclic Pifithrin-α ≥95% | 60477-38-5 | 10mg | $195 | 2024-03-01 | Buy |
Cayman Chemical | 17848 | p-nitro-Cyclic Pifithrin-α ≥95% | 60477-38-5 | 25mg | $397 | 2024-03-01 | Buy |
Pifithrin-α, p-nitro, cyclic Chemical Properties,Uses,Production
Uses
p-nitro-Cyclic Pifithrin-α is an inactivator of p53 that blocks p53-dependent transcriptional activation and apoptisis. Anti-cancer agent.
General Description
A cell-permeable p53 inhibitor that exhibits 10-fold higher potency (ED50 = 30 nM in protecting etoposide-induced cortical neuron death) and 50% longer half-life (t1/2 = 6h in neuron culture medium at 37°C) than Pifithrin-α (Cat. No. 506132). However, despite its in vitro efficacy, this inhibitor is not effective when adminstered in rats in vivo. For in vivo applications, please consider Pifithrin-α, p-Nitro (Cat. No. 506152).
Biological Activity
p-nitro-cyclic pifithrin-α is an inactivator of p53.the activation of the tumor suppressor gene p53 plays a key role in regulating the in-vitro death of neurons, following apoptotic stimuli molecules including glutamate and dna-damaging agents. thus, p53 inhibitors may prove effective in suppressing the degenerative processes in neurodegenerative disorders.
Biochem/physiol Actions
Cell permeable: yes
in vitro
pifithrin-α (pft-α) was identified as an inactivator of p53 blocking p53-dependent transcriptional activation and apoptosis. cyclic pft-α was a stable analog of pft-α. p-nitro-cyclic pft-α, a cell-permeable form of cyclic pft-α, was found to be one order of magnitude more active than pft-α in protecting cortical neurons exposed to etoposide. p-nitro-cyclic pft-α acted in a p53-dependently but did not block phosphorylation of p53 on ser15 in response to etoposide treatment, although it prevented p53 posttranscriptional activity [1].
in vivo
in a previou study, c57bl/6 mice were fed a high-fat (hfd) or control diet for 8 weeks; pft was administered three times per week. results showed that pft administration could suppress hfd-induced weight gain, steatosis, oxidative stress, alt elevation, and apoptosis. pft treatment also able to blunt the hfd-induced upregulation of mirna34a and increase sirt1 expression. in the livers of hfd-fed, pft-treated mice, activation of the sirt1/pgc1α/pparα axis increased the expression of malonyl-coa decarboxylase [2].
References
[1] . pietrancosta, n.,moumen, a.,dono, r., et al. imino-tetrahydro-benzothiazole derivatives as p53 inhibitors: discovery of a highly potent in vivo inhibitor and its action mechanism. journal of medicinal chemistry 49(12), 3645-3652 (2006).
[2] derdak z, villegas ka, harb r, wu am, sousa a, wands jr. inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease. j hepatol. 2013 apr;58(4):785-91.
Pifithrin-α, p-nitro, cyclic Preparation Products And Raw materials
Raw materials
Preparation Products
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 | ivan@atkchemical.com | China | 33024 | 60 |
TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 | marketing@targetmol.com | United States | 32159 | 58 |
TargetMol Chemicals Inc. | support@targetmol.com | United States | 38630 | 58 | |
LEAPCHEM CO., LTD. | +86-852-30606658 | market18@leapchem.com | China | 43340 | 58 |
Shanghai Acmec Biochemical Technology Co., Ltd. | +86-18621343501; +undefined18621343501 | product@acmec-e.com | China | 33338 | 58 |
Aladdin Scientific | tp@aladdinsci.com | United States | 52924 | 58 | |
SHANGHAI KEAN TECHNOLOGY CO., LTD. | +8613817748580 | cooperation@kean-chem.com | China | 40066 | 58 |
SHANGHAI FORTUNE CHEMICAL TECHNOLOGY CO., LTD | 13816107857 | sales@fortunechem-sh.com | China | 825 | 58 |
Sigma-Aldrich | 021-61415566 800-8193336 | orderCN@merckgroup.com | China | 51456 | 80 |
Shanghai YuanYe Biotechnology Co., Ltd. | 021-61312847; 18021002903 | 3008007409@qq.com | China | 71829 | 60 |
View Lastest Price from Pifithrin-α, p-nitro, cyclic manufacturers
Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
---|---|---|---|---|---|---|---|---|
![]() |
2024-11-18 | Pifithrin-α, p-Nitro, Cyclic
60477-38-5
|
US $34.00-80.00 / mg | 99.43% | 10g | TargetMol Chemicals Inc. | ||
![]() |
2024-11-18 | Pifithrin-α, p-Nitro, Cyclic
60477-38-5
|
US $34.00-80.00 / mg | 99.43% | 10g | TargetMol Chemicals Inc. |
-
- Pifithrin-α, p-Nitro, Cyclic
60477-38-5
- US $34.00-80.00 / mg
- 99.43%
- TargetMol Chemicals Inc.
-
- Pifithrin-α, p-Nitro, Cyclic
60477-38-5
- US $34.00-80.00 / mg
- 99.43%
- TargetMol Chemicals Inc.